Market Overview

DA Davidson Favors Lifeway Foods Over Dean Foods

Share:
DA Davidson Favors Lifeway Foods Over Dean Foods

  • On Thursday, DA Davidson analyst Eric M. Gottlieb explained why he prefers Lifeway Foods, Inc. (NASDAQ: LWAY) over Dean Foods Co (NYSE: DF).
  • In two separate reports, the expert issued a Buy rating on Lifeway and a Neutral rating on Dean.
  • In addition, the analyst issued a 12–18 month price target of $14 and a 5-year price target of $25 for the former, and a 12–18 month price target of $19 and a 5-year price target of $21 for the latter.
  • Lifeway Foods

    While the company has been around for almost 30 years, analyst Eric Gottlieb at DA Davidson believes that it is “just starting to gain momentum.”

    The report pointed out a few issues related to the Buy thesis. First off, Gottlieb feels that “mainstream America, with their changing views on healthy living, appears now more ready than ever for kefir,” a product similar to a drinkable yogurt. However, the mass is still uneducated regarding the product’s benefits.

    Related Link: Dean Foods Falling After Morgan Stanley Downgrade

    Secondly, Gottlieb stated that the company’s new Wisconsin production facility unlocks further potential. Moreover, since “Lifeway Foods has already begun executing its plan to increase awareness, production capability, and distribution,” it’s only a matter of time before sales explode as its markets expand.

    Dean Foods

    On the other hand, Gottlieb does not see so much potential in Dean Foods. The expert noted that, while branded initiatives should help the company deliver wider and more stable margins, a declining milk demand dampens its growth prospects. “Milk prices should remain manageable in FY2016, which should provide at least a short-term opportunity for some success, while the operational turnaround continues to add benefits. Looking further out, milk prices will likely be cyclical and create periods of outperformance and underperformance,” the note expounded.

    Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.

    Image Credit: Public Domain

    Latest Ratings for LWAY

    DateFirmActionFromTo
    Jun 2018TerminatesSpeculative BuySpeculative Buy
    Sep 2016MaintainsBuy
    Dec 2015Initiates Coverage onBuy

    View More Analyst Ratings for LWAY
    View the Latest Analyst Ratings

    Posted-In: Analyst Color Long Ideas Price Target Commodities Reiteration Top Stories Markets Analyst Ratings Best of Benzinga

     

    Related Articles (LWAY + DF)

    View Comments and Join the Discussion!

    Major Pharma Group Outlook In 2016: Fundamentals To Outweigh Political Headwinds

    JPMorgan Sees 'Another Step In The Right Direction' For Sunedison